CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company...
Year: 2025
Avalyn Appoints Industry Veterans Jill Denning and Kimberley Cummings to Leadership
Appointments expand clinical and regulatory capabilities ahead of key program milestonesBOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc.,...
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
MADRID and CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical...
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty...
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating...
COUR Pharma Secures FDA Orphan Drug Designation for CNP-106 in Generalized Myasthenia Gravis
CHICAGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for...
CorVista Health Appoints Guido Neels and Dino Trevisani to Board of Directors
Veteran MedTech leader Guido Neels joins CorVista, leveraging his experience as EW Healthcare Partners Operating Partner and former Guidant COO.Company...
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead...
Stryker to announce financial results for its third quarter of fiscal year 2025
Portage, Michigan, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its third...
ATMA CENA Grows National Mental Health Network to 13 Clinics
Expanding access to safe, regulated psychedelic-assisted therapy across Canada CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ATMA CENA, a...
Solid Biosciences to Present at Upcoming Scientific Meetings
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic...
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
- Meeting date aligns with prior guidance - - FDA to review AEON’s analytical development plan and initial data -...
SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the...
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical...
Akanda Discusses Altán Redes $7 Billion Project
Unprecedented Scale and Investment to Connect MexicoToronto, Ontario--(Newsfile Corp. - October 1, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and...
New Report Breaks Down Risk Assessments for Practical Application as 80% of OCR Settlements Cite Documentation Failures
Regulatory Attorneys and Compliance Veterans Provide Clear Guidance on Healthcare's Most Confusing Compliance Requirement as Enforcement Actions Intensify NEW YORK,...
Quintessence Psychiatry Adopts Mentavi’s Mental Health Diagnostic Evaluation to Offer More Rigorous, Timely ADHD Assessments in Private Practice
Early Patient Feedback Points to Clearer Understanding of Results and Smoother Treatment Planning GRAND RAPIDS, MICHIGAN / ACCESS Newswire /...
Scryb Grants Stock Options
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") announces that...
Timeero Helps Home Care Agencies Simplify EVV Compliance
CHANDLER, Ariz. , Sept. 30, 2025 /PRNewswire/ -- For many home care agencies, a single missing EVV record can cost thousands....
11th Annual ISS National Lab and NSF Announce Funding Opportunity for Physical Science Research on Space Station
Also, six new projects from previous NSF/CASIS joint solicitations were selected to advance tissue engineering and transport phenomena research through...